chrisvoncsefalvay/vaers-outcomes huggingface dataset:
CAN NOT WORK; TIRED; DON NOT HAVE ENERGY ANYMORE ANYWAY; COMMUNICATION VERY HARD NOW A DAYS; EYE ROLLED BACK IN HEAD AND WAS NOT THERE; FUNNY TASTE IN MOUTH; TEMPERATURE CHANGE/TEMPERATURE THE NEXT DAY AFTER VACCINATION; LETHARGIC TYPE STUFF; FELT LIKE HAD A FLU BUG/FLU-EYE TYPE STUFF; OUT OF CONTROL SPASMS AND THEY WERE CLENCHING THE JAW TO SHUT AND ARCHING BACK AND MAKING NOT ABLE TO MOVE ARMS AND LEGS WHEN THEY CALM DOWN; VISION ISSUES; BALANCE ISSUES; MUSCLE ACHES; COULD NOT TYPE ANYMORE AND BRAIN DOES NOT FUNCTION IN NUMBERS ANY MORE; LARYNGEAL SPASMS; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had no allergic reactions to anything. The patient had no previous issues that would contribute. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A expiry: 23-JUN-2021) dose was not reported, administered on 12-APR-2021 for covid-19 prophylaxis. Age at time of vaccination 62 years old. No concomitant medications were reported. On 2021, the patient experienced could not type anymore and brain does not function in numbers any more, and laryngeal spasms. Laboratory data included: MRI not reported. On APR-2021, the patient experienced lethargic type stuff, felt like had a flu bug/flu-eye type stuff, out of control spasms and they were clenching the jaw to shut and arching back and making not able to move arms and legs when they calm down, vision issues, balance issues, and muscle aches. On 13-APR-2021, the patient experienced funny taste in mouth, and temperature change/temperature the next day after vaccination. Laboratory data included: Body temperature temperature change. On OCT-2021, the patient experienced eye rolled back in head and was not there. On 2022, the patient experienced communication very hard now a days, and don not have energy anymore anyway. Laboratory data included: Diagnostic ultrasound not reported. On an unspecified date, the patient experienced can not work, and tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from out of control spasms and they were clenching the jaw to shut and arching back and making not able to move arms and legs when they calm down, balance issues, communication very hard now a days, and laryngeal spasms, and the outcome of funny taste in mouth, lethargic type stuff, felt like had a flu bug/flu-eye type stuff, vision issues, muscle aches, could not type anymore and brain does not function in numbers any more, eye rolled back in head and was not there, don not have energy anymore anyway, tired, can not work and temperature change/temperature the next day after vaccination was not reported. This report was non-serious. This case, involving the same patient is linked to 20221248752.
Approximately 2 days after given GARDASIL inj. pt developed a rash on trunk, back, and arms. Pt was given BENADRYL and HYDROCORT cream daily. This is in follow-up has been received from a health professional concerning a 13 year old female who on 10-AUG-2007 was vaccinated IM in the right arm with the first dose of GARDASIL vaccine. (658219/0680U). Per the reporter, when the patient went home she experienced a "rash all over her body lasting for several days to 1 week." The patient was instructed to take BENADRYL (25mg prn). Subsequently, the patient recovered from the rash. No further information was provided. Additional information is not expected.
My vision got much worse beginning the day after the shot. It got even worse after the second shot. I now require glasses for both reading and far vision. Prior to the vaccine I did not wear glasses.
strange pink or dark tinge urine; Normal Fatigue; Aches; flu like symptoms; This is a spontaneous report from a non-contactable physician. A patient of unspecified age and gender received unknown dose number of BNT162B2 (Covid 19 vaccine), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient experienced the normal fatigue, aches, flu like symptoms for 2 or 3 days. She had strange pink or dark tinge urine. After week, had urine test, all was normal. Events took place after use of product. Outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Mother states 2 days post vaccination that site of injection is red, with swelling, hardness and warmth. No fever. Seen by MD on 05/16/13; note states cellulitis and abscess, unspecified. Mother states child has pain to site but no spread of redness.
received the 1st Dose of the Moderna Vaccine, Later the Patient received a Dose of the Pfizer Vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (received the 1st Dose of the Moderna Vaccine, Later the Patient received a Dose of the Pfizer Vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (received the 1st Dose of the Moderna Vaccine, Later the Patient received a Dose of the Pfizer Vaccine). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (received the 1st Dose of the Moderna Vaccine, Later the Patient received a Dose of the Pfizer Vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported No treatment medications were reported
right arm/hand felt very tingly and numb briefly; right arm/hand felt very tingly and numb briefly; felt some chest discomfort; Gerd; indigestion; I had diarrhea; This is a spontaneous report from a contactable Other-HCP. This 50-year-old (non-pregnant) female other-HCP reported for herself that she received bnt162b2 (FIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EM9810), dose 1 via an unspecified route of administration, administered in Arm Right on 13Feb2021 11:30 as 1ST DOSE, SINGLE DOSE for covid-19 immunisation.  Medical history included asthma, rubber sensitivity and drug hypersensitivity from an unknown date and unknown if ongoing. Concomitant medication included tetanus vaccine taken for an unspecified indication as tetanus (vaccine 4 week/1 day prior) and Vitamins NOS for an unspecified indication start and stop date were not reported. Patient don't have covid prior vaccination. The patient experienced felt some chest discomfort, Gerd (gastrooesophageal reflux disease), indigestion and i had diarrhea on 13Feb2021 13:30 and right arm/hand felt very tingly and numb briefly on 17Feb2021. Reported as when I initially had the vaccine, I felt some chest discomfort that later felt like Gerd/indigestion. Then 2 hours later and several times throughout day I had diarrhea. 3 days after my right arm/hand felt very tingly and numb briefly. The patient underwent lab tests and procedures which included sars-cov-2 test: unknown result on 01Mar2021, sars-cov-2 test: unknown result on 01Mar2021. Patient had not received any treatment for the events reported. The outcome of the events was resolved on an unspecified date.   No follow-up attempts are possible. No further information is expected.
Gave a second dose from vials that were expired past the 12 hours mark this morning; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Gave a second dose from vials that were expired past the 12 hours mark this morning) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Gave a second dose from vials that were expired past the 12 hours mark this morning). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Gave a second dose from vials that were expired past the 12 hours mark this morning) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant product use was provided.   No Treatment information was provided.  Pharmacist stated that one of her interns accidentally gave 2 patients a second dose from vials that were expired past the 12 hours mark this morning 21Aug2021 at 8:25am (vial was open since yesterday 20Aug2021, punctured at 1:35pm). She wanted to know if they need to be revaccinated right away or not?  Both shots (first and second) were given in the left deltoid muscle for both patients.
10/9/14 received FLUVAX. 10/12/14 awoke with numbness dull ache Rt arm shoulder blade "nerve pain" radiated across shoulder, lower back persistent. Took ALEVE x2 with improvement. Continued through day- evening with RLS. 10/13/14 still with RLS. Rt leg weakness, rt arm weakness, difficult to ambulate. MD 10/14/14 to Doctor. Weakness remains Rt arm/leg.
Fever, weakness in left side of body (vaccine was given in left arm), numbness in left arm, dizziness, fatigue, foggy minded, difficulties concentrating, severe shoulder and neck pain in left side.
body & facial rash 10 days p/vax;mom described as pus filled blisters in clusters;
Patient was anxious upon recieving the vaccine. About 5 minutes after the shot patient became sweaty, confused, light-headed, and then experienced a loss of conciousness. I had her sit in the floor upon feeling light-headed, she then proceded to lay down and then passed out. We called 911 at that point. She was out for maybe 1 minute. When coming back to she had some forgetfullness. I dont think she remembered passing out. She refused to keep laying down and said she was fine then proceded to sit back in the chair. I was talking to her and she kept telling me she was fine but then she passed out again. This time was again for about a minute. She stayed seated in the chair with her head slumped and was unresponsive, and again was out for about 1 minute. After coming back this time she seemed completely fine. Was talking normal and kept telling me she felt much better. EMS arrived and she refused to have her any of her vitals checked and demanded that she leave. I tried to follow up with her that evening on the phone but couldnt get ahold of her.
Seen in office 2/6, left upper arm 11x9cm warmth, erythema.  Firm swelling.  Right upper arm 3x3cm warmth, erythema.  Mom will call if does not improve.
Vomiting immediately after vaccine x 2, then again 15 min later then 30 min after vaccine, developed urticaria of extremities and face.
pt recv vax 13OCT97 & pt exp neck pain & overall did not feel well;
Double pneumococcal pneumonia; Double pneumococcal pneumonia; Received a contaminated batch; Received a contaminated batch; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 2 patients. This is 2nd of 2 reports. A female patient of an unspecified age received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13, lot number and expiry date unknown), via an unspecified route of administration on an unspecified date at single dose for routine vaccination. Medical history included HIV from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced double pneumococcal pneumonia on an unspecified date. The reporter reported that there were two patients received the same vaccine and got double pneumococcal pneumonia after receiving it, both patients received a contaminated batch. The outcome of double pneumococcal pneumonia was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2019457002 same reporter/drug, different patient/event.
On 3/3/00, the pt returned for the 2nd Hep B vaccine. When asked how she had done on her last visit, the child and grandmother referenced a late onset of pain and discomfort 30 minutes after vaccine in right leg from hip to toes. Child describes "like I bruised my whole leg. The pt also complained of numbness and tingling, unable to walk without difficulty. Discomfort lasted most of the night with slight soreness in the morning. Eventually the pt's symptoms resolved without sequela.
Pt recvd vax & exp acneform boils, fatigue & low grade fever; reporter indicates that pt MD dx pt as having diabetes mellitus;
The client reported tingling diffusely on her left arm. The client denied any other symptoms. Vitals obtained at 4:12 PM were as follows: BP 100/74, HR 84, O2 99%. The client then reported the numbness was "getting better" and was only present in her hand that this time. Vitals obtained at 4:17 PM were as follows: BP 108/72, HR 88, O2 99%. The client reported her hand still felt "numb." RN provided education to the client and her mother regarding s/s of anaphylaxis and when to seek EMS. The client and her mother voiced understanding of this education. Repeat vitals obtained at 4:27PM were as follows: BP 104/70, HR 83, O2 99. RN noted the client's hand strength was equal bilaterally. The client reported a history of Lyme disease, currently under control without medications. RN  asked the client how the numbness was currently and the client stated "I think it's done." Vitals obtained at 4:40 PM were as follows: BP 102/70, HR 73, O2 98%. The client stated she felt "normal." The client ambulated unassisted with a steady gait out of the vaccination site at 4:41PM.
fever; weakness; feeling bad; This case was reported by a consumer via call center representative and described the occurrence of fever in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, unknown after receiving Shingrix, the patient experienced fever, weakness and feeling bad. On an unknown date, the outcome of the fever, weakness and feeling bad were recovered/resolved.   It was unknown if the reporter considered the fever, weakness and feeling bad to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The caller was husband of the patient who received dose of Shingrix. The caller reported that the patient experienced fever, weakness, feeling bad that resolved after a few days. For tolerance to next dose, refer case US2019AMR122601.
Patient's significant other was present throughout encounter. Patient began experiencing muffled hearing and darkened vision approximately 30 seconds after receiving vaccine. He stated he does have a history of needle phobia and fainting from previous (non-COVID) vaccinations. He did become lightheaded and dizzy but did not lose consciousness. Patient also experienced some palpitations. Requested first response to be called so he could be brought to the emergency department (ED). He stated that these symptoms are in line with anxiety attacks he has had in the past, except the muffled hearing which is a new symptom. First response arrived, spoke with the patient, and the patient agreed to go the the ED.
One day post vax pt awoke with pox marks on her belly and a fever. Over the next 24 hours the pts condition progressed to full blown chickenpox with greater than 50 lesions on her face, scalp, genitalia, legs and abdomen.
Large red blotch covering upper arm at injection site. Itchy. Irregular menstrual cycle after both injections
Vax- Fluzone HD (unable to enter in box 17)  Returned from PCP and started to experience sudden chills. Used covers/blankets to keep warm and eventually fell asleep. Attempted to get up to pee, but I couldn't move. Body/muscles felt extremely heavy. Took aprox. 20-30 minutes to edge myself to edge of the bed so that I could fall to the floor. Urinated on floor since I was unable to move. Around 3am I was able to inch myself to onto a chair, where I proceeded to call my doctor. Sister took me to see the doctor every day after vaccination.  Complained of the above symptoms and labored breathing. Given albuterol.
This spontaneous report as received from a medical assistant refers to an approximately 19 months old patient of an unknown gender. The patient was vaccinated subcutaneously with the first dose of MMR II (dose and lot number not reported) on their first birthday in November 2009. No other co-suspects were reported. No concomitant medications were reported. In June 2010 the patient was vaccinated with the second dose of MMR II (dose and lot number not reported). No adverse effect was reported. Additional information has been requested.
Pt Presented to Administering Pharmacy on 5/14/18 reporting bilateral "tingling" sensation in both arms. Pt states that this sensation is very similar to his two previous bouts with shingles and is concerned that the administration of the vaccine may have activated dormant zoster in his body. Pt also reported significant symptoms of lethargy and malaise starting approximately 48 hours following the vaccine administration and continuing for approximately 72 hours after symptoms appeared. Pt  self treated with bed rest. Pt did not report this to pharmacy until 5/14/2018.
Got flu vaccine on 10/16/2020 then rash started appearing the next day. Few days later it was confirmed that shingles developed.
Thrombocytopenia. No bruising or symptoms stated since last dose of vaccine on 01/27/2021. Patient just went for annual labs and discovered it. Experienced Dry. crusty rash on body. Patient is on high-dose corticosteroid therapy. Patient seeing Hematologist.
Patient received the Moderna 1st dose on April last days. He´s still waiting the 2nd dose. (more than 3 months later!); This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient received the Moderna 1st dose on April last days. He´s still waiting the 2nd dose. (more than 3 months later!)) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient received the Moderna 1st dose on April last days. He´s still waiting the 2nd dose. (more than 3 months later!)). In April 2021, PRODUCT DOSE OMISSION ISSUE (Patient received the Moderna 1st dose on April last days. He´s still waiting the 2nd dose. (more than 3 months later!)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided. No treatment medication were provided. .
Client inadvertently received ZOSTAVAX instead of Chickenpox varicella, CDC called no further f/u. Parent informed of local reaction to look for. Supervisor notified.
This spontaneous report was received from a registered nurse referring to multiple unknown number of patients of unknown age and gender. The patients' pertinent medical history, drug reactions/allergies and concomitant medication were not reported. On unknown dates, the patients was each vaccinated with an improperly stored dose of GARDASIL 9 (lot # M018810 with expiration date 28-MAY-2018, dosage and route of administration were not reported) for prophylaxis, which were exposed to temperature excursion (temperature: 51.3 degrees Fahrenheit, time frame: 1 hour) because of data logger. There was no previous temperature excursion. No product quality complaint was involved. This is one of the several reports from the same reporter. Follow up information has been received from the nurse on 03-NOV-2016. Product information and narrative were updated. All telephone attempts on 22-DEC-2016 to obtain follow-up information have been unsuccessful. Additional information has been requested. Narrative was updated. Sender's Comments: US-009507513-1611USA000902:Original Case : 1611USA000845, US-009507513-1611USA000903:Original Case : 1611USA000845, US-009507513-1611USA000901:Original Case : 1611USA000845, MERCK 1611USA000845:Mfr number.
Intermittent tingling and numbness in the left fingers, left side of the face/head and left lower back.  Persistent tingling and numbness in the left leg.  Bursitis in the left hip.   Intermittent swelling in the gums and teeth pain.
This spontaneous report as received from a registered nurse refers to a 17 year old patient of unknown gender. Pertinent medical history and concurrent conditions were not reported. At the time of this report, the patient had none drug reactions or allergies. On 13-APR-2015 the patient was vaccinated with GARDASIL, 0.5 ml, once, intramuscular, (dose number, anatomical location, lot number and expiration date were unspecified). Concomitant therapies included adapalene for topical dermatologic treatment and albuterol sulfate (manufacturer unknown). On 14-APR-2015 the patient experienced muscular weakness, nausea, chills and pyrexia. The reporter stated that the patient went to the emergency room, at the hospital, and was treated with intravenous fluids (unspecified) and MOTRIN; then, the patient was released. On 16-APR-2015, the patient experienced throat irritation, headache and a return of the symptoms previously mentioned (muscular weakness, nausea, chills and pyrexia). The patient returned to the emergency room and was again treated with intravenous fluids (unspecified) and MOTRIN, and then released. Laboratory diagnostic studies performed, on an unspecified date in 2015, included "strep and flu tests" (unspecified); which resulted negative. The outcome of throat irritation, headache, nausea, chills, pyrexia and muscular weakness was reported as recovered/resolved (also reported as "doing fine now"). The relatedness between the events and GARDASIL was not reported. Additional information has been requested.
Angioedema ? large hives, swelling of face and eyes, itching and fatigue
mom reported on 18OCT94 pt began screaming @ time of immun (130PM) until 830PM w/o stopping; 830 pt fell asleep; no fever; mom gave APAP 7PM & 1AM; mom noted bruise & fifty cents size knot upper thigh; 13SEP PM bruise gone;knot remains
Lightheaded, blurred vision, flushed feeling, shaky, tightness in neck, diaphoretic.  Evaluated by EMS. 1:09PM -Jaw slightly tight. 1:20 pm pain, stiffness  traveling to mid back.  1:25 pm neck feeling better, no nausea, tinling in hands, no change in sensation in legs. 1:30pm remains lightheaded,  vision remains blurry, c/o left sided chest discomfort when pressure  applied, pain and stiffness in neck returning.  1:42 pm transported to Hospital by rescue squad.